Cas 143154-06-7,N-benzylidene α-amino-3-[(dimethoxyphosphinyl)methyl]-2-quinoxalinepropanoic acid ethyl ester

143154-06-7

Post Buying Request

Basic information

Product Name: N-benzylidene α-amino-3-[(dimethoxyphosphinyl)methyl]-2-quinoxalinepropanoic acid ethyl ester
Synonyms:
CAS NO:143154-06-7
Molecular Formula:
Molecular Weight: 455.45
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-benzylidene α-amino-3-[(dimethoxyphosphinyl)methyl]-2-quinoxalinepropanoic acid ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: N-benzylidene α-amino-3-[(dimethoxyphosphinyl)methyl]-2-quinoxalinepropanoic acid ethyl ester(143154-06-7)
EPA Substance Registry System: N-benzylidene α-amino-3-[(dimethoxyphosphinyl)methyl]-2-quinoxalinepropanoic acid ethyl ester(143154-06-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 143154-06-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

143154-06-7 Suppliers

Recommended suppliers

143154-06-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 143154-06-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,1,5 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 143154-06:
(8*1)+(7*4)+(6*3)+(5*1)+(4*5)+(3*4)+(2*0)+(1*6)=97
97 % 10 = 7
So 143154-06-7 is a valid CAS Registry Number.

143154-06-7Upstream product

143154-06-7Downstream Products

143154-06-7Relevant academic research and scientific papers

QUINOXALINE PHOSPHONO-AMINO ACIDS

-

, (2008/06/13)

The compounds of the formula: STR1 in which Q is the quinoxaline nucleus; m is one of the integers 0, 1 or 2; n is one of the integers 1,2 or 3; or a pharmaceutically acceptable salt, alkyl ester or STR2 where R. sup.3 and R 4 are, independently, hydrogen, nitro, halo or methoxy, are NMDA antagonists useful in the treatment and prevention of central nervous system related pathological conditions resulting from overstimulation by excitatory amino acids.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 143154-06-7